Skip to content

Clinical trials

Expanded access trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Expanded access Country / region: South Korea Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062
20141

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Approved for marketing10
No longer available5
Available4
Temporarily not available2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Novartis Pharmaceuticals2
Pfizer2
Astellas Pharma Global Development, Inc.1
BioMarin Pharmaceutical1
Biotoxtech Co., Ltd1
Boehringer Ingelheim1
Genexine, Inc.1
IGM Biosciences, Inc.1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung3
Breast Neoplasms2
Adenocarcinoma1
Burns, Chemical1
Carcinoma, Renal Cell1
Colonic Neoplasms1
Gastrointestinal Neoplasms1
Genital Diseases, Male1
Genital Neoplasms, Male1
Glioblastoma1

Trials

Showing 76 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.